Cargando...
Successful treatment of refractory hyperferritinemic syndromes with canakinumab: a report of two cases
BACKGROUND: Hyperferritinemic syndromes are systemic inflammatory disorders characterized by a dysfunctional immune response, which leads to excessive activation of the monocyte-macrophage system with hypercytokinemia and may pursue a rapidly fatal course. CASE PRESENTATION: We describe two patients...
Guardado en:
| Publicado en: | Pediatr Rheumatol Online J |
|---|---|
| Autores principales: | , , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
BioMed Central
2020
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7353681/ https://ncbi.nlm.nih.gov/pubmed/32653009 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12969-020-00450-9 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|